Clinical Presentation & Protocol
Patient Usually Complains Of
Patient presents for evaluation of sporadic gastric neuroendocrine tumor (Type III). Symptoms include [epigastric pain/dyspepsia/weight loss/anemia]. No history of hypergastrinemia, atrophic gastritis, or MEN-1 syndrome. Tumor is solitary, sporadic, and typically >2 cm at presentation.
Clinical Examination Findings
Physical exam reveals [stable/unstable] vitals. Abdominal exam: [soft/distended], [non-tender/tender] to palpation in the epigastrium, no palpable masses or hepatomegaly. Skin: no signs of carcinoid syndrome (flushing/telangiectasia). Lymphadenopathy: [absent/present].
Treatment Protocol
Management plan: Surgical resection is the primary treatment (gastrectomy with regional lymphadenectomy) due to high malignant potential. Post-operative surveillance includes serial endoscopy and cross-sectional imaging (CT/MRI) to monitor for recurrence or metastatic disease. Somatostatin analogs considered if metastatic.